Apps and online services AI NOV 18, 2026 7 MIN READ

Babylon Health

My post on failed products examples covers twelve famous cases from tech and why each one failed.

Timeline of Babylon Health: 10 dated events from April 2014 to August 31, 2023, drawn from the entry's sources.Timeline of Babylon Health: 10 dated events from April 2014 to August 31, 2023, drawn from the entry's sources.
Every date is from the entry's sources below. An original diagram, free to reuse with a link to this page · Download the SVG
The timeline as text
  • April 2014Launched in the UK as a £7.99-a-month app for GP consultations
  • June 2018Said its chatbot beat the average human score on MRCGP questions
  • August 2019Announced a $550 million round at a valuation of more than $2 billion
  • October 21, 2021Completed its SPAC merger and listed its shares on the NYSE
  • August 2022Ended its partnership with the Royal Wolverhampton NHS Trust
  • March 16, 2023Annual report raised substantial doubt about it as a going concern
  • June 2023Said it expected the NYSE to delist its shares
  • August 7, 2023MindMaze deal off; Babylon said it was exiting its core US business
  • August 9, 2023Filed for Chapter 7 bankruptcy for two US subsidiaries in Delaware
  • August 31, 2023Announced its UK business had been acquired by eMed
Company
Babylon Health
Category
Apps and online services
Launched
April 2014
Ended
August 2023
Stage reached
Growth
AI product
Yes
Status
Babylon announced the sale of its UK business to eMed on August 31, 2023, after exiting its core US business

Babylon Health failed because its losses outran its funding. By 2022 most of its revenue came from contracts with US health plans that made it pay for patients' care, and when a deal to take it private fell through in August 2023, it said it had no binding commitment for more financing.

What it was

Babylon Health was a UK-based digital health company that sold doctor consultations through a phone app, later with an AI symptom checker built in. Ali Parsa founded it in 2013, its annual report says.

It launched in the UK in April 2014, Wired reported, giving subscribers access to doctors 12 hours a day, six days a week, for £7.99 a month.

The annual report dates its NHS work through GP at Hand, a digital-first practice, to 2017, and its US value-based care service, Babylon 360, to 2020. Under its value-based contracts, Babylon negotiated a fixed allocation per member per month with a health plan and would "assume financial responsibility for member healthcare services."

What happened

At a June 2018 event, Babylon said its chatbot scored 81% on questions from the MRCGP, the exam trainee GPs sit, against an average of 72% for human doctors, the BBC reported.

In August 2019 it announced a $550 million funding round at a valuation of more than $2 billion, from investors including Saudi Arabia's Public Investment Fund, TechCrunch reported.

On October 21, 2021, Babylon completed a merger with Alkuri Global Acquisition Corp, a special purpose acquisition company, and listed its shares on the NYSE. TechCrunch had put its equity value after the deal at around $4.2 billion.

By August 2022 the shares had fallen from around $10 to less than $1, TechCrunch reported. That month Babylon ended a partnership with the Royal Wolverhampton NHS Trust that had been announced as a 10-year deal.

On March 9, 2023, Babylon said its 2022 revenue had grown 3.5 times, to $1.11 billion, with a net loss of $221.4 million, and that it expected adjusted EBITDA profitability in mid-2024.

Its annual report, filed on March 16, put value-based care at 92.5% of that revenue. It also said its past results and its dependence on raising more capital meant "substantial doubt exists" about its ability to continue as a going concern.

In June Babylon chose a take-private plan from its lender, AlbaCore Capital, and MindMaze, a Swiss digital therapeutics company, and said it expected the NYSE to delist its shares.

On August 7, 2023, Babylon said the MindMaze deal would not proceed and that it was "exiting its core US business." It told a Texas agency it would close its Austin headquarters that day and lay off 94 employees, Forbes reported.

The next day Centene, whose agreements made up 48.1% of Babylon's 2022 revenue, terminated its Babylon contracts, except three with Babylon's California physician network, Babylon disclosed.

Babylon filed for Chapter 7 bankruptcy for two US subsidiaries in Delaware, to liquidate them, in filings dated August 9, Forbes reported.

On August 31, Babylon said its UK business, substantially all its remaining assets, had been acquired by eMed, with no payment to shareholders. Its UK subsidiary had formally gone into administration the night before, TechCrunch reported.

Why it failed

Babylon Health failed because it couldn't secure more financing, its filings show, while carrying contracts that could lose money when patients' care cost more than the fees. Reporting showed doctors disputing its AI claims, and the UK device regulator telling a clinician it shared his concerns.

What Babylon said

Babylon's statements pointed to money. On August 7, 2023, it said it had "no binding commitment for additional financing to continue its business operations."

Its annual report had warned that if medical costs exceeded the PMPM allocations, the fixed monthly amounts it was paid per member, "we could suffer losses." In 2022 its claims expense came to 99.1% of its value-based care revenue. The report also said Babylon had incurred losses since its inception, with an accumulated deficit of $836.8 million at the end of 2022.

In the UK, Tim Rideout, Babylon's general manager there, told TechCrunch in August 2022 that the Wolverhampton partnership "just wasn't economically viable," as NHS funding pressures grew and capital got more expensive. Parsa told analysts the small NHS contracts it ended were "a distraction," Wired reported.

What reporting showed

The Royal College of General Practitioners said it hadn't given Babylon its exam questions and had no way to verify the 2018 claim, the BBC reported.

Babylon's own doctors audited the chatbot before a December 2017 meeting with Parsa, two insiders told Forbes in 2018. They found that around 10% to 15% of its 100 most frequently suggested outcomes missed warning signs of a more serious condition or were wrong, according to one insider.

Hamish Fraser, a Brown University professor who had disputed Babylon's claims in The Lancet, told Forbes the software had answered only 15 of the 50 exam problems and was allowed three answers to each. Babylon told Forbes it wasn't trying to show the AI was better than doctors.

In 2021, TechCrunch reported a letter in which the MHRA, the UK's medical device regulator, told a clinician who had raised concerns about patient safety and governance at Babylon since 2017, "Your concerns are all valid and ones that we share."

On the money, TechCrunch's Alex Wilhelm set Babylon's first-quarter 2022 revenue of $266.5 million against $271.5 million in insurance claims and care delivery costs, which by his eye made it "effectively gross-margin negative."

Wired reported in August 2022 that GP at Hand, the NHS practice Babylon kept, wasn't making a profit.

In May 2023, BTIG analyst David Larsen wrote that early revenue from Babylon's value-based contracts "can be at an extremely low, or negative, gross margin" until savings arrive, which can take years, Forbes reported.

The stage it reached

Babylon Health reached the growth stage, the second of the four product life cycle stages, when sales climb fast on new customers.

That fits 2022. Babylon said its revenue rose 3.5 times on growth in US value-based care membership, which reached over 261,000, up 1.6 times in a year.

It never reached maturity. Babylon had lost money since its inception and was still looking for financing when the MindMaze deal fell through, so I count it as a collapse in growth, not a decline.

The lesson

I think the chatbot fights are the smaller part of Babylon's story. The bigger part is a business that grew by taking on the cost of patients' care, on the promise that digital care would make that care cheaper.

In that model, revenue rises with the risk you carry. Babylon reported 3.5 times the revenue and, a week later, a going-concern warning.

The AI and the money share a root, as I see it. A former staffer told Forbes there was "no system in place to find out" what happened to patients after they used the chatbot, though Babylon said its app messaged users 24 hours later. That's hand-wavy evaluation, with patients on the other end.

If your revenue depends on your product lowering someone's costs, prove it does on real customers before you sign contracts that assume it.

Causes at a glance

  • Company statementBusiness model and costs

    It said it lacked committed financing after the MindMaze deal fell through

    Source11

  • Company statementBusiness model and costs

    Its annual report warned it could lose money when care cost more than its fees

    Source1

  • Reporting at the timeBusiness model and costs

    TechCrunch and a BTIG analyst saw negative or extremely low gross margins

    Sources3,20

  • Reporting at the timeAccuracy

    Doctors disputed its AI claims, and the UK regulator called a critic's concerns valid

    Sources4,18,19

Sources

  1. 1.
    Babylon Holdings (SEC filing), Annual Report on Form 10-K for the fiscal year ended December 31, 2022

    March 2023 · Company statement

  2. 2.
    Wired UK, Babylon app puts a GP in your pocket

    April 2014 · Reporting at the time

  3. 3.
    TechCrunch, Babylon Health dials back some services in the UK

    August 2022 · Reporting at the time

  4. 4.
    BBC News, Babylon claims its chatbot beats GPs at medical exam

    June 2018 · Reporting at the time

  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
    Babylon (SEC filing), Babylon Announces Update on Take Private Proposal

    June 2023 · Company statement

  10. 10.
  11. 11.
    Babylon (SEC filing), Babylon In Discussions of New Strategic Alternatives for its Businesses

    August 2023 · Company statement

  12. 12.
  13. 13.
    Babylon Holdings (SEC filing), Form 8-K: Centene's non-renewal and termination of Babylon contracts

    August 2023 · Company statement

  14. 14.
  15. 15.
    Babylon Holdings (SEC filing), Form 8-K: sale of the UK business to eMed

    August 2023 · Company statement

  16. 16.
  17. 17.
    Wired UK, Babylon Disrupted the UK's Health System. Then It Left

    August 2022 · Reporting at the time

  18. 18.
  19. 19.
  20. 20.
    Forbes, InnovationRx: Babylon 'May Trade To Zero,' Analyst Says

    May 2023 · Reporting at the time

Share this entry